Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Bostwick

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
American Journal of Therapeutics|July 22, 2006
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trialSteven R Alberts, Paul J Novotny, Jeff A Sloan, et al.
The Journal of Nutrition|August 28, 2009
Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized ratsLeecole L Legette, Berdine R Martin, Mohammad Shahnazari, et al.
The Journal of Urology|September 25, 2012
Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 casesE David Crawford, Kyle O Rove, Edouard J Trabulsi, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancerJennifer I Swalwell, Cathy D Vocke, Youfeng Yang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytesDavid J Waters, Shuren Shen, Huiping Xu, et al.
JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 27, 2003
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysisCarolyn J M Best, Isabel M Leiva, Rodrigo F Chuaqui, et al.
The New England Journal of Medicine|April 2, 2010
Effect of dutasteride on the risk of prostate cancerGerald L Andriole, David G Bostwick, Otis W Brawley, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
BJU International|November 18, 2020
Prostate cancer grading, time to go back to the futureLars Egevad, Brett Delahunt, David G Bostwick, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
American Journal of Therapeutics|July 22, 2006
Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trialSteven R Alberts, Paul J Novotny, Jeff A Sloan, et al.
The Journal of Nutrition|August 28, 2009
Supplemental dietary racemic equol has modest benefits to bone but has mild uterotropic activity in ovariectomized ratsLeecole L Legette, Berdine R Martin, Mohammad Shahnazari, et al.
The Journal of Urology|September 25, 2012
Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 casesE David Crawford, Kyle O Rove, Edouard J Trabulsi, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Determination of a minimal deletion interval on chromosome band 8p21 in sporadic prostate cancerJennifer I Swalwell, Cathy D Vocke, Youfeng Yang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 15, 2007
Noninvasive prediction of prostatic DNA damage by oxidative stress challenge of peripheral blood lymphocytesDavid J Waters, Shuren Shen, Huiping Xu, et al.
JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 27, 2003
Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysisCarolyn J M Best, Isabel M Leiva, Rodrigo F Chuaqui, et al.
The New England Journal of Medicine|April 2, 2010
Effect of dutasteride on the risk of prostate cancerGerald L Andriole, David G Bostwick, Otis W Brawley, et al.
The Prostate|May 22, 2014
Correlation of HOXD3 promoter hypermethylation with clinical and pathologic features in screening prostate biopsiesLeonard N Chen, Rachel S Rubin, Eugide Othepa, et al.
BJU International|November 18, 2020
Prostate cancer grading, time to go back to the futureLars Egevad, Brett Delahunt, David G Bostwick, et al.
Pageof 12